Novavax Announces Positive Top-Line Results From Phase 1 Clinical Trial of RSV Vaccine Candidate in Elderly

barbara.lempert   —  Well-tolerated without any vaccine-related serious adverse events   —  Adjuvant enhanced response seen in all dose levels   —  Anti-F ...

FDA slaps a clinical hold on Achillon hep C drug

Tracy Staton Shares of Achillion skidded down 20% as the FDA put a clinical hold on its hepatitis C drug sovaprevir. FiercePharma News

FDA Puts Achillion Pharmaceuticals’ Phase II Drug on Clinical Hold

barbara.lempert Achillion Provides Update on Sovaprevir Development Program Following Phase 1 drug-drug interaction study with ritonavir-boosted atazanavir showing elevated ...

Soligenix Completes Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohn’s Disease

barbara.lempert Princeton, NJ – June 28, 2013 – Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing ...

Pergamum reports positive follow-up data from a Phase II clinical trial of PXL-01 for prevention of post-surgical adhesions

barbara.lempert STOCKHOLM – June 27, 2012. Pergamum AB announced today that several end-points were met in a randomized Phase II trial of PXL-01 for prevention of post-surgical adhesions. ...

Verastem Initiates Phase 1 Clinical Trial of VS-4718 in Patients with Advanced Cancer

barbara.lempert –VS-4718 is the Second Cancer Stem Cell Inhibitor to Enter Clinical Development– CAMBRIDGE, Mass.–(BUSINESS WIRE)–Verastem, Inc., (NASDAQ: ...

Peregrine Pharmaceuticals Provides Update on Bavituximab Clinical Program

barbara.lempert Company Strengthens Cash Position as It Prepares to Initiate Phase III Trial in Second-Line NSCLC by Year-End While Partnering Discussions Continue; Recent Data Supporting ...

XOMA’s Development Partner SERVIER Launches Proof-of-Concept Clinical Program for Gevokizumab

barbara.lempert Program Will Be Initiated With the Launch of a Study in Polymyositis/Dermatomyostis BERKELEY, Calif., June 25, 2013 (GLOBE NEWSWIRE) — XOMA Corporation ...

Highland Therapeutics Announces Positive Clinical Results for HLD-200 – A Novel ADHD Therapeutic

barbara.lempert •    Positive results achieved in Phase 1 HLD-200 study ; confirm second pipeline product •    Results further validate Highland’s drug-delivery technology ...

Pharming And Santarus Announce Poster Presentation Of Pivotal Clinical Data For Ruconest

barbara.lempert Pharming And Santarus Announce Poster Presentation Of Pivotal Clinical Data For Ruconest® (recombinant Human C1 Esterase Inhibitor) LEIDEN, Netherlands and SAN DIEGO ...

Mitsubishi Chemical Medience and LabCorp Clinical Trials Announce Master Service Agreement

barbara.lempert Mitsubishi Chemical Medience and LabCorp Clinical Trials Announce Master Service Agreement to Offer Clients Greater Access to Global Central Lab Services Tokyo, JAPAN ...

Amarin Announces Positive Results of Phase 1 Clinical Trial

barbara.lempert Amarin Announces Positive Results of Phase 1 Clinical Trial    Measuring the Bioavailability of a Fixed-Dose Combination of           Vascepa(R) and a ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS